Clinical Trial Update: Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction [Phase 2]

View source ↗

Summary

Phase 2 study evaluating LIB003 for additional LDL-C reduction in patients on lipid-lowering therapy has completed. The trial assessed efficacy and safety of LI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• LIB003

Snippet

Sponsor: LIB Therapeutics LLC | Conditions: LDL Cholesterol | Phase 2 | Status: COMPLETED